Breaking News Instant updates and real-time market news.

CSPLF

Countryside Properties

$3.55 /

+0.03 (+0.85%)

14:39
04/19/22
04/19
14:39
04/19/22
14:39

Countryside price target lowered to 270 GBp from 510 GBp at Berenberg

Berenberg analyst Donald Tait lowered the firm's price target on Countryside Properties to 270 GBp from 510 GBp and keeps a Hold rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
eHealth price target lowered to $8 from $12 at Truist » 09:28
08/09/22
08/09
09:28
08/09/22
09:28
EHTH

eHealth

$8.29 /

+0.52 (+6.69%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

EHTH eHealth
$8.29 /

+0.52 (+6.69%)

05:35 Today Citi
eHealth price target lowered to $9 from $13 at Citi
05/05/22 Deutsche Bank
eHealth price target lowered to $10 from $19 at Deutsche Bank
03/31/22 Credit Suisse
eHealth assumed with a Neutral at Credit Suisse
03/21/22 Citi
eHealth downgraded to Neutral from Buy at Citi
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

EHTH eHealth
$8.29 /

+0.52 (+6.69%)

Syndicate
Aytu BioPharma 21.5M share Spot Secondary priced at 43c » 09:27
08/09/22
08/09
09:27
08/09/22
09:27
AYTU

Aytu BioPharma

/

+

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioPharma
/

+

AYTU Aytu BioPharma
/

+

07/21/22 H.C. Wainwright
Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright
05/17/22 Cantor Fitzgerald
Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald
04/28/22 H.C. Wainwright
Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright
  • 09
    Aug
Syndicate
Medicenna Therapeutics 13.333M share Spot Secondary priced at $1.50 » 09:25
08/09/22
08/09
09:25
08/09/22
09:25
MDNA

Medicenna Therapeutics

$1.77 /

+0.04 (+2.31%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22 Oppenheimer
Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer
03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

  • 09
    Aug
Initiation
Coupang initiated with an Outperform at Macquarie » 09:24
08/09/22
08/09
09:24
08/09/22
09:24
CPNG

Coupang

$19.20 /

-0.04 (-0.21%)

Macquarie analyst Danny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

CPNG Coupang
$19.20 /

-0.04 (-0.21%)

06/30/22 Credit Suisse
Coupang upgraded to Outperform at Credit Suisse following underperformance
06/30/22 Credit Suisse
Coupang upgraded to Outperform from Neutral at Credit Suisse
06/29/22 Morgan Stanley
Coupang initiated with an Overweight at Morgan Stanley
05/12/22 Mizuho
Coupang price target lowered to $18 from $28 at Mizuho
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

  • 14
    Sep
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

CPNG Coupang
$19.20 /

-0.04 (-0.21%)

CPNG Coupang
$19.20 /

-0.04 (-0.21%)

Recommendations
Nvidia price target lowered to $216 from $283 at Truist » 09:23
08/09/22
08/09
09:23
08/09/22
09:23
NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

Truist analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

07:07 Today Susquehanna
Nvidia price target lowered to $210 from $220 at Susquehanna
06:41 Today Mizuho
Nvidia price target lowered to $250 from $290 at Mizuho
08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

Hot Stocks
WISeKey implementing post-quantum algorithms » 09:22
08/09/22
08/09
09:22
08/09/22
09:22
WKEY

WISeKey

$2.66 /

+0.03 (+1.14%)

During the last two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKEY WISeKey
$2.66 /

+0.03 (+1.14%)

WKEY WISeKey
$2.66 /

+0.03 (+1.14%)

05/02/22 H.C. Wainwright
WISeKey price target lowered to $4 from $11 at H.C. Wainwright
02/01/22 Maxim
WISeKey price target cut to $8 from $11 at Maxim
12/10/21 Maxim
WISeKey initiated with a Buy at Maxim
Hot Stocks
Strong Studios to develop, produce film on Joe Moglia » 09:21
08/09/22
08/09
09:21
08/09/22
09:21
BTN

Ballantyne Strong

$2.65 /

-0.02 (-0.75%)

Strong Studios, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTN Ballantyne Strong
$2.65 /

-0.02 (-0.75%)

Recommendations
Crispr Therapeutics price target raised to $69 from $55 at Stifel » 09:21
08/09/22
08/09
09:21
08/09/22
09:21
CRSP

Crispr Therapeutics

$81.33 /

-0.02 (-0.02%)

Stifel analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

07:20 Today Credit Suisse
Crispr Therapeutics price target raised to $90 from $74 at Credit Suisse
05:33 Today Barclays
Crispr Therapeutics downgraded to Equal Weight from Overweight at Barclays
08/08/22 Chardan
Crispr Therapeutics price target lowered to $154 from $164 at Chardan
08/02/22 Citi
Crispr Therapeutics price target raised to $83 from $53 at Citi
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

Recommendations
CarGurus price target lowered to $27 from $32 at Needham » 09:20
08/09/22
08/09
09:20
08/09/22
09:20
CARG

CarGurus

$25.77 /

+0.01 (+0.04%)

Needham analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

CARG CarGurus
$25.77 /

+0.01 (+0.04%)

08:32 Today DA Davidson
CarGurus price target lowered to $30 from $34 at DA Davidson
07:53 Today Raymond James
CarGurus price target lowered to $28 from $34 at Raymond James
07:37 Today Oppenheimer
CarGurus price target lowered to $32 from $38 at Oppenheimer
07:16 Today Truist
CarGurus price target lowered to $38 from $44 at Truist
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

CARG CarGurus
$25.77 /

+0.01 (+0.04%)

Hot Stocks
Aytu BioPharma announces pricing of public offering » 09:18
08/09/22
08/09
09:18
08/09/22
09:18
AYTU

Aytu BioPharma

/

+

Aytu BioPharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioPharma
/

+

AYTU Aytu BioPharma
/

+

07/21/22 H.C. Wainwright
Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright
05/17/22 Cantor Fitzgerald
Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald
04/28/22 H.C. Wainwright
Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright
  • 09
    Aug
Recommendations
Turtle Beach price target lowered to $18 from $32 at Lake Street » 09:18
08/09/22
08/09
09:18
08/09/22
09:18
HEAR

Turtle Beach

$14.00 /

-0.145 (-1.03%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

07:36 Today DA Davidson
Turtle Beach downgraded to Neutral from Buy at DA Davidson
07:30 Today Oppenheimer
Turtle Beach downgraded to Perform on weaker outlook at Oppenheimer
07:26 Today Wedbush
Turtle Beach price target lowered to $12 from $22 at Wedbush
06:38 Today Oppenheimer
Turtle Beach downgraded to Perform from Outperform at Oppenheimer
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

Hot Stocks
E2open expands partnership with Shippeo » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
ETWO

E2open

$7.41 /

+0.21 (+2.92%)

E2open and Shippeo have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETWO E2open
$7.41 /

+0.21 (+2.92%)

ETWO E2open
$7.41 /

+0.21 (+2.92%)

04/28/22 Loop Capital
E2open price target lowered to $12 from $16 at Loop Capital
04/21/22 BofA
E2open upgraded to Buy at BofA on accelerating revenue growth
04/21/22 BofA
E2open upgraded to Buy from Neutral at BofA
03/23/22 Colliers
E2open upgraded to Buy from Neutral at Colliers
ETWO E2open
$7.41 /

+0.21 (+2.92%)

ETWO E2open
$7.41 /

+0.21 (+2.92%)

Hot Stocks
Medicenna Therapeutics announces pricing of $20M public offering » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
MDNA

Medicenna Therapeutics

$1.77 /

+0.04 (+2.31%)

Medicenna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22 Oppenheimer
Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer
03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

  • 09
    Aug
Hot Stocks
Ralph Lauren seeing broad based strength across all regions » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
RL

Ralph Lauren

$101.19 /

+0.96 (+0.96%)

Says not immune to macro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

08/05/22 Credit Suisse
Ralph Lauren price target lowered to $120 from $130 at Credit Suisse
08/01/22 Deutsche Bank
Ralph Lauren price target lowered to $99 from $101 at Deutsche Bank
07/21/22 Goldman Sachs
Ralph Lauren price target lowered to $78 from $85 at Goldman Sachs
07/15/22 UBS
Ralph Lauren price target lowered to $129 from $162 at UBS
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

Recommendations
SI-Bone price target lowered to $24 from $28 at Needham » 09:16
08/09/22
08/09
09:16
08/09/22
09:16
SIBN

SI-Bone

$16.52 /

-0.21 (-1.26%)

Needham analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

05/10/22 Canaccord
SI-Bone price target lowered to $25 from $32 at Canaccord
04/07/22 Cantor Fitzgerald
SI-Bone assumed with an Overweight at Cantor Fitzgerald
12/21/21 Truist
SI-Bone price target lowered to $30 from $35 at Truist
11/09/21 Needham
SI-Bone price target lowered to $32 from $37 at Needham
SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

Hot Stocks
Nova Vision Acquisition announces additional contribution to trust account » 09:16
08/09/22
08/09
09:16
08/09/22
09:16
NOVV

Nova Vision Acquisition

$10.06 /

+ (+0.00%)

Nova Vision Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Linde downgraded to Reduce from Add at Baader Helvea » 09:15
08/09/22
08/09
09:15
08/09/22
09:15
LIN

Linde

$301.02 /

-0.99 (-0.33%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIN Linde
$301.02 /

-0.99 (-0.33%)

LIN Linde
$301.02 /

-0.99 (-0.33%)

08/02/22 Deutsche Bank
Linde price target lowered to EUR 350 from EUR 352 at Deutsche Bank
07/29/22 Deutsche Bank
Linde price target lowered to $355 from $370 at Deutsche Bank
07/29/22 JPMorgan
Linde price target lowered to $350 from $360 at JPMorgan
07/13/22 BofA
Linde price target lowered to $369 from $370 at BofA
LIN Linde
$301.02 /

-0.99 (-0.33%)

LIN Linde
$301.02 /

-0.99 (-0.33%)

LIN Linde
$301.02 /

-0.99 (-0.33%)

Recommendations
DermTech price target lowered to $14 from $34 at Lake Street » 09:15
08/09/22
08/09
09:15
08/09/22
09:15
DMTK

DermTech

$8.42 /

-0.02 (-0.24%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DMTK DermTech
$8.42 /

-0.02 (-0.24%)

DMTK DermTech
$8.42 /

-0.02 (-0.24%)

08:46 Today Craig-Hallum
DermTech price target lowered to $18 from $37 at Craig-Hallum
07/18/22 Oppenheimer
DermTech assumed with an Outperform at Oppenheimer
05/09/22 BTIG
DermTech transferred with a Buy at BTIG
05/04/22 Cowen
DermTech price target lowered to $20 from $33 at Cowen
DMTK DermTech
$8.42 /

-0.02 (-0.24%)

DMTK DermTech
$8.42 /

-0.02 (-0.24%)

Hot Stocks
Aware appoints Herman as CRO » 09:15
08/09/22
08/09
09:15
08/09/22
09:15
AWRE

Aware

$2.22 /

+0.15 (+7.25%)

, CRM

Salesforce

$189.83 /

-0.42 (-0.22%)

Aware (AWRE) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AWRE Aware
$2.22 /

+0.15 (+7.25%)

CRM Salesforce
$189.83 /

-0.42 (-0.22%)

AWRE Aware
$2.22 /

+0.15 (+7.25%)

09/13/21 Lake Street
Aware initiated with a Buy at Lake Street
CRM Salesforce
$189.83 /

-0.42 (-0.22%)

09:11 Today UBS
UBS sees 'downtick' in partner tone ahead of Salesforce earnings
07/18/22 Piper Sandler
Salesforce price target lowered to $220 from $250 at Piper Sandler
06/02/22 Loop Capital
Salesforce price target lowered to $175 from $225 at Loop Capital
06/01/22 RBC Capital
Salesforce margin outlook overshadowed lower revenue guide, says RBC Capital
CRM Salesforce
$189.83 /

-0.42 (-0.22%)

CRM Salesforce
$189.83 /

-0.42 (-0.22%)

CRM Salesforce
$189.83 /

-0.42 (-0.22%)

CRM Salesforce
$189.83 /

-0.42 (-0.22%)

Hot Stocks
Rockley Photonics gets first commercial order for Rockley Bioptx band » 09:15
08/09/22
08/09
09:15
08/09/22
09:15
RKLY

Rockley Photonics

$2.04 /

-0.235 (-10.33%)

Rockley Photonics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/13/22 Needham
Rockley Photonics price target lowered to $4 from $8 at Needham
03/09/22 Northland
Rockley Photonics price target lowered to $10 from $20 at Northland
RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

RKLY Rockley Photonics
$2.04 /

-0.235 (-10.33%)

General news
Treasury Action: yields are extending their cheapening bent » 09:15
08/09/22
08/09
09:15
08/09/22
09:15
$ECON

Economic Data

/

+

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Burford Capital reports 1H EPS (10c) vs. (13c) last year » 09:14
08/09/22
08/09
09:14
08/09/22
09:14
BUR

Burford Capital

$10.90 /

+0.12 (+1.11%)

Reports 1H revenue $106M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BUR Burford Capital
$10.90 /

+0.12 (+1.11%)

BUR Burford Capital
$10.90 /

+0.12 (+1.11%)

05/13/22 B. Riley
Burford Capital initiated with a Buy at B. Riley
03/24/22 Peel Hunt
Burford Capital upgraded to Buy from Add at Peel Hunt
BUR Burford Capital
$10.90 /

+0.12 (+1.11%)

Recommendations
Trex Company price target lowered to $58 from $67 at DA Davidson » 09:14
08/09/22
08/09
09:14
08/09/22
09:14
TREX

Trex Company

$63.74 /

-0.91 (-1.41%)

DA Davidson analyst Kurt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TREX Trex Company
$63.74 /

-0.91 (-1.41%)

TREX Trex Company
$63.74 /

-0.91 (-1.41%)

08:28 Today B. Riley
Trex Company should be bought on earnings selloff, says B. Riley
08:00 Today Stifel
Trex Company price target lowered to $68 from $77 at Stifel
07:41 Today Truist
Trex Company price target lowered to $85 from $90 at Truist
05:49 Today Barclays
Trex Company price target lowered to $53 from $63 at Barclays
TREX Trex Company
$63.74 /

-0.91 (-1.41%)

TREX Trex Company
$63.74 /

-0.91 (-1.41%)

Hot Stocks
SKYX Platforms achieves U.S. standardization approval vote » 09:13
08/09/22
08/09
09:13
08/09/22
09:13
SKYX

SKYX Platforms

$6.20 /

-0.32 (-4.91%)

SKYX Platforms announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKYX SKYX Platforms
$6.20 /

-0.32 (-4.91%)

SKYX SKYX Platforms
$6.20 /

-0.32 (-4.91%)

07/27/22 Benchmark
SKYX Platforms initiated with a Buy at Benchmark
SKYX SKYX Platforms
$6.20 /

-0.32 (-4.91%)

  • 10
    Feb
SKYX SKYX Platforms
$6.20 /

-0.32 (-4.91%)

SKYX SKYX Platforms
$6.20 /

-0.32 (-4.91%)

Earnings
Stereotaxis reports Q2 EPS (7c) vs (2c) last year » 09:13
08/09/22
08/09
09:13
08/09/22
09:13
STXS

Stereotaxis

$2.59 /

+0.04 (+1.57%)

Reports Q2 revenue $6.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STXS Stereotaxis
$2.59 /

+0.04 (+1.57%)

STXS Stereotaxis
$2.59 /

+0.04 (+1.57%)

07/12/22 Aegis
Stereotaxis initiated with a Buy at Aegis
06/23/22 B. Riley
B. Riley starts 'reaccelerating growth story' Stereotaxis at Buy
06/23/22 B. Riley
Stereotaxis initiated with a Buy at B. Riley
04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
STXS Stereotaxis
$2.59 /

+0.04 (+1.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.